Pfizer Slashes Fiscal Year Guidance as It Lowers Revenue From Covid-19 Treatments by $9 Billion
By Sabela Ojea Pfizer is launching a multi-year cost-cutting plan as it slashes its revenue expectations for the year due to lower sales related to Covid-19. The healthcare giant on Friday...